Silvio Garattini

Last updated
Silvio Garattini
Silvio Garattini 1963.jpg
Silvio Garattini in 1963
Born(1928-11-12)12 November 1928
Bergamo, Italy
Nationality Italian
Occupation(s)Physician, chemist, researcher in the field of pharmacology, professor of chemotherapy, director of the Mario Negri Institute for Pharmacological Research
Years active1963 to date
Employer Mario Negri Institute for Pharmacological Research
Parents
  • Aristotele Garattini
  • Silvia Viaro
AwardsKnight of the Order of Merit of the Italian Republic
Website www.marionegri.it

Silvio Garattini (born in Bergamo November 12, 1928) is an Italian scientist, pharmacology research scientist, physician and professor in chemotherapy and pharmacology and director of the Mario Negri Institute for Pharmacological Research. [1]

Contents

Biography

Chemical technical specialist and medical doctor, he began his career as an assistant at the Pharmacology Institute [2] of the University of Milan where he remained until 1962 as a senior lecturer in pharmacology and chemotherapy. [3]

In 1963 he founded the Mario Negri Institute for Pharmacological Research of which he became the first director. [3] Over the years, the institute developed to reach staffing of approximately 850 researchers over four different locations in Milan, Bergamo, Ranica and Santa Maria Imbaro. [4]

From 1965 to 1968 he chaired the European Organisation for Research and Treatment of Cancer (EORTC); he is a component of the "Group 2003", [5] a group of Italian researchers held in high esteem in the global pharmaceutical environment. [6]

Garattini is the author of hundreds of publications in international journals and author of several treatises on pharmacology. [3]

During his career he was a member of several national and international organizations, [7] among which are the Committee of Biology and Medicine of the National Research Council (CNR), the Italian National Health Council and the Council of Ministers of the Presidency Commission for research policy in Italy, as well as Member of the Single Commission of the drug (CUF) of Italian Ministry of Health.

Other positions he held include: [8]

He is a fellow of the New York Academy of Sciences, of the American Association for the Advancement of Science and emeritus fellow of the Royal College of Physicians [10] }.

During his long career he received numerous national and international honours, including: the Legion of Honour of the French Republic for scientific merits, Grand Official of Italian Republic and several honorary degrees from several European universities. He received the America Award of the Italy-USA Foundation in 2018.

Controversies

In 1996 he was criticized by supporters of the Di Bella method because he denied, as a member of the CUF (single commission of the drug), moving somatostatin from the H band to a group A drug which would have provided for the free supply of the drug. This was due to the lack of scientific proof of its effectiveness. [11] He is also criticized by the animalist movements for his favourable position towards animal testing and for having responded to their accusations of gratuitous violence on animals "animal testing is irreplaceable and necessary. Those opposed will have to assume their responsibilities for care and drugs that will not be found. Research cannot be stopped". [12] [13]

Honours and recognition

Italy

ITA OMRI 2001 Com BAR.svg - Commanders of the Order of Merit of the Italian Republic - Awarded on December 27, 1990. [14]

Grande ufficiale OMRI BAR.svg - Grand Officer Order of Merit of the Italian Republic - Awarded on December 27, 2005. [15]

Benemeriti della salute pubblica gold medal BAR.svg - Gold Medal awarded on February 1, 2010. [16]

Europe

Legion Honneur Chevalier ribbon.svg - Knight of Legion of Honour on 1984. [17]

Honoris Causa from Autonomous University of Barcelona in 1982. [18]

Honoris Causa from University of Białystok in 1984 [19]

Notes and references

  1. ↑ "Silvio Garattini". www.thelancet.com. 1997-02-08. Retrieved 2017-08-11.
  2. ↑ "La sera andavamo in via Statuto: i giessini, dal Berchet al potere". Corriere della sera (in Italian). 1999-08-25.
  3. 1 2 3 "Silvio Garattini". marionegri.it. IRCCS Istituto di Ricerche Farmacologiche Mario Negri. Retrieved January 16, 2017.
  4. ↑ "Silvio Garattini". www.scienceonthenet.eu. Retrieved 2017-08-11.
  5. ↑ "Soci Gruppo 2003". gruppo 2003 (in Italian). Retrieved January 16, 2017.
  6. ↑ "Diamo un futuro alla ricerca italiana". scienzainrete.it (in Italian). Retrieved January 16, 2017.
  7. ↑ Cesare Fassari (2012-02-16). "Garattini all'Aifa. Un ritratto del Guru del farmaco in "dolcevita"". quotidianosanita.it (in Italian). Retrieved January 16, 2017.
  8. ↑ "Silvio Garattini". www.cicap.org. CICAP. 2004. Retrieved 2017-08-11.
  9. ↑ "Prof. Silvio Grattini". natsyndrugs.org (in Italian). Retrieved January 16, 2017.
  10. ↑ Wynants, Marleen (2009). In Sickness and in Health: The Future of Medicine : Added Value & Global Access. ISBN   9789054875499 . Retrieved January 16, 2017.
  11. ↑ .html intervista Garattini
  12. ↑ Articolo su Il Corriere
  13. ↑ Progetto Gaia
  14. ↑ "Commendatore Ordine al Merito della Repubblica Italiana". www.quirinale.it (in Italian). Retrieved January 16, 2017.
  15. ↑ "Grande Ufficiale Ordine al Merito della Repubblica Italiana". www.qurinale.it (in Italian). Retrieved January 16, 2017.
  16. ↑ "Medaglia d'oro al merito della sanità pubblica". www.quirinale.it (in Italian). Retrieved January 16, 2017.
  17. ↑ Light, Donald W.; Maturo, Antonio F. (2015-06-30). Good Pharma. ISBN   9781137374332 . Retrieved January 16, 2017.
  18. ↑ "Doctors honoris causa". UAB. Retrieved January 16, 2017.
  19. ↑ "Doktorzy honoris causa". umb.edu.pl. Retrieved January 16, 2017.

Related Research Articles

<span class="mw-page-title-main">Daniel Bovet</span> Swiss-born Italian pharmacologist

Daniel Bovet was a Swiss-born Italian pharmacologist who won the 1957 Nobel Prize in Physiology or Medicine for his discovery of drugs that block the actions of specific neurotransmitters. He is best known for his discovery in 1937 of antihistamines, which block the neurotransmitter histamine and are used in allergy medication. His other research included work on chemotherapy, sulfa drugs, the sympathetic nervous system, the pharmacology of curare, and other neuropharmacological interests.

<span class="mw-page-title-main">Luigi di Bella</span> Italian physiologist and writer (1912-2003)

Luigi Di Bella was an Italian medical doctor and physiology professor. In the late 1980s, he created a purported treatment known as "Di Bella therapy" for cancer that precipitated an international controversy.

<span class="mw-page-title-main">V. Craig Jordan</span> American-British pharmacologist (1947–2024)

Virgil Craig Jordan,, was an American and British scientist specializing in drugs for breast cancer treatment and prevention. He was Professor of Breast Medical Oncology, and Professor of Molecular and Cellular Oncology at the University of Texas MD Anderson Cancer Center, Houston, Texas. Previously, he was Scientific Director and Vice Chairman of Oncology at the Lombardi Comprehensive Cancer Center of Georgetown University. Jordan was the first to discover the breast cancer prevention properties of tamoxifen and the scientific principles for adjuvant therapy with antihormones. His later work branched out into the prevention of multiple diseases in women with the discovery of the drug group, selective estrogen receptor modulator (SERMs). He later worked on developing a new Hormone Replacement Therapy (HRT) for post-menopausal women that prevents breast cancer and does not increase the risk of breast cancer.

<span class="mw-page-title-main">Gordon McVie</span> British oncologist and cancer researcher (1945–2021)

John Gordon McVie was an international authority on the treatment and research of cancer. He wrote over 350 peer-reviewed articles, editorials and books. McVie was born in Glasgow, Scotland and died of non-Hodgkin lymphona and COVID-19 in Bristol, England.

Enrico Alleva is an Italian ethologist. He has been president of the Società Italiana di Etologia since 2008.

<span class="mw-page-title-main">Francesco Bellini</span> Canadian businessman and scientist

Francesco Bellini, is an Italian-born research scientist, administrator, and Quebecer businessman.

<span class="mw-page-title-main">Mario Negri Institute for Pharmacological Research</span> Nonprofit research institute in Italy

The Mario Negri Institute for Pharmacological Research is a nonprofit research institute dedicated to clinical and biomedical research. It was made possible by a special bequest of Milan philanthropist Mario Negri. It was founded in 1961 although it started working in Milan from 1st Feb 1963. There are branches of the institute in Bergamo, Ranica (BG), and at Santa Maria Imbaro, near Chieti.

<span class="mw-page-title-main">Georges Mathé</span> French oncologist and immunologist (1922–2010)

Georges Mathé was a French oncologist and immunologist. In November 1958, he performed the first successful allogeneic bone marrow transplant ever performed on unrelated human beings.

<span class="mw-page-title-main">Giacomo Devoto</span> Italian historical linguist (1897–1974)

Giacomo Devoto was an Italian historical linguist and one of the greatest exponents of the twentieth century of the discipline. He was born in Genoa and died in Florence.

<span class="mw-page-title-main">Simonetta Di Pippo</span> Italian physicist

Simonetta Di Pippo is an Italian astrophysicist and former Director of the United Nations Office for Outer Space Affairs (UNOOSA). She holds a Master’s Degree in Astrophysics and Space Physics from University "La Sapienza", and an Honoris Causa Degree in Environmental Studies, and an Honoris Causa Degree of Doctor in International Affairs. In 2008, the International Astronomical Union (IAU) named asteroid 21887 "dipippo" in honour of her contribution to space activities and in 2006, she was knighted by the President of the Italian Republic Carlo Azeglio Ciampi.

<span class="mw-page-title-main">Claudio Carosino</span> Italian physician

Claudio Carosino, MD was an Italian general practitioner and family physician, tutor and mentor engaged in rural medicine. Carosino was shot and killed by a patient while performing a house visit in the rural village of Roncole Verdi in Italy.

Alessandro Liberati was an Italian healthcare researcher and clinical epidemiologist, and founder of the Italian Cochrane Centre.

<span class="mw-page-title-main">Paul Workman (scientist)</span> British oncologist (born 1952)

Paul Workman is a British scientist noted for his work on the discovery and development of pharmaceutical agents in the field of oncology. He is President and CEO of The Institute of Cancer Research In London.

<span class="mw-page-title-main">Gian Luigi Gessa</span>

Gian Luigi Gessa is a professor of Neuropsychopharmacology at the University of Cagliari, where he has led for a long time the Department of Neurosciences. He is the leader of the Italian group that studies drug addiction. He also directed the research groups of the National Research Council.

Cora Sternberg is an American medical oncologist.

Kurt Hellmann was a Bavarian clinical pharmacologist best known for his discovery of the biologic activity of two important drugs: Razoxane and Dexrazoxane.

<span class="mw-page-title-main">Alberto Mantovani</span> Italian physician and immunologist (born 1948)

Alberto Mantovani is an Italian physician and immunologist. He is Scientific Director of Istituto Clinico Humanitas, President and Founder of the Fondazione Humanitas per la Ricerca, and Professor of Pathology at the State University of Milan. He is known for his works in the roles of the immune system in the development of cancer. His research on tumor-associated macrophages established inflammation as one of the causes of cancer. He was the first to identify monocyte chemotactic protein - 1 / CCL2 in 1983, and PTX3 in 1997. His works revealed the existence of decoy receptors in cell-signalling. He has been the most cited scientist in Italy, and one of the ten most cited immunologists worldwide.

The Metastasis Research Society (MRS) is an international professional society dedicated to metastasis research and treatment. Headquartered in Tampa, Florida, the MRS was formed in 1974 as the E.O.R.T.C. Metastasis Club by Bavarian clinical pharmacologist Kurt Hellmann and Director of the Mario Negri Institute for Pharmacological Research Silvio Garattini. It took its current name in the mid-1980s, with its first international meeting as a formal society in 1984 in London.

<span class="mw-page-title-main">Luciano Onder</span> Italian journalist and science broadcaster

Luciano Onder is an Italian journalist and science broadcaster, best known for presenting the shows Medicina 33 and TG5 Salute.

John A. Hickman is a British-French cancer pharmacologist.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.